共 136 条
[1]
Meshram RJ(2022)Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections Arch Virol 167 717-736
[2]
Kathwate GH(2006)The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 45 529-538
[3]
Gacche RN(2020)Hepatitis C virus and chronic kidney disease Expert Rev Gastroenterol Hepatol 14 579-590
[4]
Perz JF(2022)The world prevalence, associated risk factors and mortality of hepatitis C virus infection in hemodialysis patients: a meta-analysis J Nephrol 35 2269-2282
[5]
Armstrong GL(2022)Hepatitis C seroconversion remains high among patients with regular hemodialysis: study of associated risk factors Int J Hepatol. 30 493-500
[6]
Farrington LA(2021)Progress in hepatitis C virus management in chronic kidney disease Curr Opin Nephrol Hypertens 20 388-165
[7]
Hutin YJ(2019)Clinical practice guideline management of blood borne viruses within the haemodialysis unit BMC Nephrol 8 91-947
[8]
Bell BP(2018)2018 KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease Kidney Int Suppl (2011) 95 939-167
[9]
Khan MU(2019)Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients Kidney Int 23 151-830
[10]
Mahmoud MI(2017)Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: a systematic review and meta-analysis World J Gastroenterol 21 164-1721